Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin,
ClinicalTrials.gov study NCT07120217. IPD Sharing: Not stated. Countries: 0. Publications: 0.
MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06557330. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
ClinicalTrials.gov study NCT01490801. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04635683. IPD Sharing: NO. Countries: 0. Publications: 0.
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
ClinicalTrials.gov study NCT00045877. IPD Sharing: Not stated. Countries: 1. Publications: 0.
(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT05923502. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)
ClinicalTrials.gov study NCT05518318. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT06465446. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00363636. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement
ClinicalTrials.gov study NCT00992758. IPD Sharing: YES. Countries: 0. Publications: 0.
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00310128. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT02762448. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT05711628. IPD Sharing: YES. Countries: 0. Publications: 0.
Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG
ClinicalTrials.gov study NCT00061425. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00100737. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT06761911. IPD Sharing: NO. Countries: 0. Publications: 0.
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).
ClinicalTrials.gov study NCT00301314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
ClinicalTrials.gov study NCT00045864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02497898. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03003039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.